Navigation Links
Scientists Spot New Clues to HIV-Linked Dementia
Date:10/6/2011

THURSDAY, Oct. 6 (HealthDay News) -- Researchers have identified two genetically distinct types of HIV in the cerebrospinal fluid (CSF) of patients with HIV-associated dementia.

The discovery may help explain why the risk of developing neurological difficulties increases as AIDS patients live longer, and may also help predict which patients are at greatest risk for the problem, according to the U.S. scientists.

They said the two newly-identified HIV types aren't being detected in HIV that circulates in a patient's blood, and one type may be present cerebrospinal fluid years before the onset of HIV-linked dementia.

The fact that the two HIV types can be detected in the CSF indicates that they grow in the central nervous system, the researchers said.

The finding might also help explain while highly active antiretroviral therapy -- the drug "cocktails" that HIV-positive patients take to stay healthy -- can help prevent some of the neurological troubles associated with infection, but not all.

The study, which appears in the Oct. 6 issue of the journal PLoS Pathogens, was led by researchers at the University of North Carolina at Chapel Hill School of Medicine.

Besides spotting the two types of HIV in cerebrospinal fluid, the team also made another discovery: While HIV is known to infect and replicate within immune system T-cells, one of the two HIV types found in CSF does so in another immune cell, called macrophages.

"This is the first time that anyone has demonstrated active replication of HIV virus in a cell type other than T- cells," study senior author Ronald Swanstrom, a professor of biochemistry and biophysics and director of the UNC Center for AIDS Research, noted in a university news release.

The finding could enhance scientists' understanding of why some patients respond better than others to HIV treatment.

"We know that HIV in the blood disappears quickly when you go on therapy, and that's because the virus is growing in T-cells, which have a very short half-life," the amount of time it takes for the level of virus to drop by half, Swanstrom explained.

But half of the patients In the new study showed a much slower rate of decay when it came to the amount of virus in their CSF. "This is evidence the virus is actually being produced by a cell with a longer half-life, and not a T-cell," Swanstrom explained.

The next step is to determine how relevant all of this might be to HIV-linked neurological issues.

"Is it bad to have these viruses around even if you don't get a diagnosis of dementia?" Swanstrom said. "And are they potentially causing cognitive damage that can be reversed with [treatment]?"

More research investigating those issues is planned, the team said.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about the neurological complications of AIDS.

-- Robert Preidt

SOURCE: University of North Carolina School of Medicine, news release, Oct. 6, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Scientists Engineer Mice That Have Autism
2. Raw Sewage a New Frontier for Scientists
3. Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit
4. 2 scientists at the University of Texas at Austin receive early career awards from White House
5. Scientists shut down pump action to break breast cancer cells drug resistance
6. President Barack Obama recognizes outstanding scientists at the Smithsonian
7. U.S. Scientists Map Genome of Advanced Prostate Cancer
8. Scientists ID More Genes Linked to Heart Disease
9. UCLA scientists find H1N1 flu virus prevalent in animals in Africa
10. Scientists Reconstruct the Movies in Our Minds
11. Scientists Discover Key Gene Mutation Behind Lou Gehrigs Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Spot New Clues to HIV-Linked Dementia
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 , ... ... the Scarborough General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned ... the Scarborough Hospital. He successfully completed his first three-year term as chief and began ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official ... NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in ... from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are ...
(Date:2/5/2016)... Pass, OR (PRWEB) , ... February 05, 2016 , ... ... with modern technology, such water may be safer than regular municipal or well water. ... advocate and radio host Sharon Kleyne, could go a long way toward increasing public ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today ... for and donate to Give To Cure’s campaign that is crowdfunding clinical trials to ... make and share payments through a smart device. In 2015 alone, Venmo processed $7.5 ...
(Date:2/5/2016)... WA (PRWEB) , ... February 05, 2016 , ... ... firm, ranked #3 in the 2015 Best in KLAS: Software & Services for ... The annual Best in KLAS report independently ranks vendor performance by healthcare executives, ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at Source Capital Group,s 2016 Disruptive Growth ... at 2:15 p.m. ET on Wednesday, February 10, 2016.  ... taking place at 3:15 p.m. ET. http://www.aethlonmedical.com .  ... after the conclusion of the live event. The panel discussion ...
(Date:2/5/2016)... York , February 5, 2016 ... Transparency Market Research report states that the global active ... 2014 and is predicted to reach US$185.9 bn by ... of 6.50% from 2014 to 2020. The title of ... Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) ...
(Date:2/5/2016)... Ind. , Feb. 5, 2016  Zimmer Biomet ... pricing of the previously announced underwritten secondary offering of ... its stockholders, consisting of affiliates of Blackstone and Goldman ... at an initial price of $96.45 per share. The ... the offering.  Neither Zimmer Biomet nor any of its ...
Breaking Medicine Technology: